Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study

作者: Andrea Silvestrini , Carmine Bruno , Edoardo Vergani , Angela Venuti , Angela Maria Rita Favuzzi

DOI: 10.1371/JOURNAL.PONE.0210320

关键词: MyokineHeart failurePathophysiologyInsulin resistanceCardiologyInsulinEjection fractionInternal medicineOxidative stressMedicineInverse correlation

摘要: Irisin, a recently discovered myokine, has been considered prognostic factor in several cardiovascular diseases. Nevertheless, no data are available on the role of irisin patients with heart failure (HF), both preserved (HFpEF) or reduced (HFrEF) ejection fraction. We have therefore evaluated circulating levels HFpEF and HFrEF patients, correlating them metabolic parameters total antioxidant capacity (TAC), as index oxidative stress. Irisin was significantly higher than (7.72 ± 0.76 vs 2.77 0.77 ng/ml, respectively). An inverse correlation between TAC found HFpEF, but not HFrEF. Conversely, present HOMA index. These support hypothesis that different pathophysiological mechanism is involved two HF subtypes, stress modulates secretion.

参考文章(21)
Catherine Rice-Evans, Nicholas J. Miller, TOTAL ANTIOXIDANT STATUS IN PLASMA AND BODY FLUIDS Methods in Enzymology. ,vol. 234, pp. 279- 293 ,(1994) , 10.1016/0076-6879(94)34095-1
Junyan Lu, Guangda Xiang, Min Liu, Wen Mei, Lin Xiang, Jing Dong, Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis. ,vol. 243, pp. 438- 448 ,(2015) , 10.1016/J.ATHEROSCLEROSIS.2015.10.020
Anh L. Bui, Tamara B. Horwich, Gregg C. Fonarow, Epidemiology and risk profile of heart failure Nature Reviews Cardiology. ,vol. 8, pp. 30- 41 ,(2011) , 10.1038/NRCARDIO.2010.165
Suna Aydin, Tuncay Kuloglu, Suleyman Aydin, Mehmet Nesimi Eren, Ahmet Celik, Musa Yilmaz, Mehmet Kalayci, İbrahim Sahin, Orhan Gungor, Ali Gurel, Murat Ogeturk, Ozlem Dabak, Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides. ,vol. 52, pp. 68- 73 ,(2014) , 10.1016/J.PEPTIDES.2013.11.024
KN Aronis, M Moreno, SA Polyzos, JM Moreno-Navarrete, W Ricart, E Delgado, J De La Hera, A Sahin-Efe, JP Chamberland, R Berman, A Spiro Iii, P Vokonas, JM Fernández-Real, CS Mantzoros, None, Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events International Journal of Obesity. ,vol. 39, pp. 156- 161 ,(2015) , 10.1038/IJO.2014.101
Joo Young Huh, Grigorios Panagiotou, Vassilis Mougios, Mary Brinkoetter, Maria T Vamvini, Benjamin E Schneider, Christos S Mantzoros, None, FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metabolism-clinical and Experimental. ,vol. 61, pp. 1725- 1738 ,(2012) , 10.1016/J.METABOL.2012.09.002
Barry A. Borlaug, David A. Kass, Ventricular–Vascular Interaction in Heart Failure Cardiology Clinics. ,vol. 29, pp. 447- 459 ,(2011) , 10.1016/J.CCL.2011.06.004
Pontus Boström, Jun Wu, Mark P. Jedrychowski, Anisha Korde, Li Ye, James C. Lo, Kyle A. Rasbach, Elisabeth Almer Boström, Jang Hyun Choi, Jonathan Z. Long, Shingo Kajimura, Maria Cristina Zingaretti, Birgitte F. Vind, Hua Tu, Saverio Cinti, Kurt Højlund, Steven P. Gygi, Bruce M. Spiegelman, A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature. ,vol. 481, pp. 463- 468 ,(2012) , 10.1038/NATURE10777
Stergios A Polyzos, Christos S Mantzoros, None, An update on the validity of irisin assays and the link between irisin and hepatic metabolism. Metabolism-clinical and Experimental. ,vol. 64, pp. 937- 942 ,(2015) , 10.1016/J.METABOL.2015.06.005